ficlatuzumab humanized monoclonal antibody designed treatment humanized monoclonal antibody binds hepatocyte growth factor thus inhibiting cmet receptor signaling ficlatuzumab developed aveo pharmaceuticals may aveo released results phase ii clinical trial comparing gefitinib alone combination ficlatuzamab treatmentnaive asian patients nonsmall cell lung monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikificlatuzumab